FI
VRTX icon

Fosun International’s Vertex Pharmaceuticals VRTX Stock Holding History

Fosun International’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-2,400
Closed -$684K – 228
2020
Q2 		$684K Sell
2,400
-1,200
-33% -$325K 0.07% 112
2020
Q1 		$835K Buy
+3,600
New +$826K 0.08% 94
2019
Q1 		– Sell
-5,000
Closed -$812K – 332
2018
Q4 		$812K Hold
5,000
– – 0.05% 163
2018
Q3 		$949K Buy
+5,000
New +$890K 0.05% 139

Other funds holding VRTX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Fosun International's VRTX Position: Q3 2020 in Review

Fosun International sold out of Vertex Pharmaceuticals (VRTX) in Q3 2020, closing a stake of 2,400 shares — an estimated $684K sold.

Fosun International first reported a position in VRTX in Q3 2018 and held it in 4 quarters. The position peaked at $949K in Q3 2018. 950 funds tracked by Wall St. Rank hold VRTX as of Q3 2020.

  • Fosun International reported no remaining Vertex Pharmaceuticals position as of Q3 2020 after selling out during the quarter.
  • Fosun International sold 2,400 Vertex Pharmaceuticals shares in Q3 2020, an estimated $684K.
  • Fosun International first reported a position in Vertex Pharmaceuticals in Q3 2018 and held it in 4 quarters.
  • Fosun International's Vertex Pharmaceuticals position peaked at $949K in Q3 2018.
  • 950 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2020.

Based on Fosun International's 13F filing for Q3 2020, filed 12 Nov 2020.